Related Experiment Videos
[Corrective treatment of immunodeficient conditions]
Terapevticheskii Arkhiv
|January 1, 1974
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
[The efficacy of leukinferon in suppurative-septic diseases].
Klinicheskaia khirurgiia·1994
[Effects of interferon preparations on the course of Salmonella infection (experimental and clinical studies)].
Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic]·1992
[The chemoluminescence of the primary focus of a suppurative infection and of isolated neutrophils exposed to dimephosphon].
Zhurnal mikrobiologii, epidemiologii i immunobiologii·1992
[Immunocorrection with pentaglobin in wound infection and burn disease].
Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic]·1991
[Sandoglobulin immunocorrection in trauma].
Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic]·1990
[Clinical and laboratory effect of leukinferon in purulent infections].
Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic]·1990
[Therapeutic drug monitoring in the treatment of patients with drug-resistant tuberculosis].
Terapevticheskii arkhiv·2026
[The Nobel Peace Prize and the role of the medical movement in addressing global challenges: the review].
Terapevticheskii arkhiv·2026
[History of the Moscow Scientific Society of Cardiology].
Terapevticheskii arkhiv·2026
Regulatory T cells in intracerebral hemorrhage: mechanisms of immunomodulation and therapeutic potential.
Frontiers in immunology·2026
Fc-engineering for improved cancer immunotherapy.
Biochemical Society transactions·2026
Explosive Multiterritorial Arterial Thrombosis Following Brief Heparin Exposure: A Diagnostic Pitfall in the Cath Lab.
Case reports in cardiology·2026
Lipophilic Ligand Efficiency-Monitored Discovery of Potent, Achiral, and Bioavailable Apo-IDO1 Inhibitors.
ACS medicinal chemistry letters·2026
Telitacicept for IgA nephropathy: a systematic review and meta-analysis of observational studies.
Frontiers in medicine·2026
Envafolimab - novel anti-PD-1/PD-L1 antibody in cancer treatment.
Frontiers in immunology·2026